Related Experiment Video
Updated: Nov 8, 2025

A Reproducible Intensive Care Unit-Oriented Endotoxin Model in Rats
Published on: February 20, 2021
Targeting STAT3: A crucial modulator of sepsis
Wangrui Lei1,2, Dianxiao Liu3, Meng Sun4
1Xi'an Key Laboratory of Cardiovascular and Cerebrovascular Diseases, Xi'an No.3 Hospital, School of Life Sciences and Medicine, Northwest University, Xi'an, China.
Abstract:
Signal transducer and activator of transcription 3 (STAT3) is a cellular signal transcription factor that has recently attracted a great deal of attention. It can trigger a variety of genes transcription in response to cytokines and growth factors stimulation, which plays an important role in many cellular biological processes involved in anti/proinflammatory responses. Sepsis is a life-threatening organ dysfunction resulting from dysregulated host responses to infection. As a converging point of multiple inflammatory responses pathways, accumulating studies have presented the elaborate network of STAT3 in sepsis pathophysiology; these results generally indicate a promising therapeutic application for targeting STAT3 in the treatment of sepsis. In the present review, we evaluated the published literature describing the use of STAT3 in the treatment of experimental and clinical sepsis. The information presented here may be useful for the design of future studies and may highlight the potential of STAT3 as a future biomarker and therapeutic target for sepsis.
Insights
Signal transducer and activator of transcription 3 (STAT3) plays a key role in inflammatory responses. Targeting STAT3 shows promise as a therapeutic strategy for sepsis treatment and as a potential biomarker.
Area of Science:
- Molecular Biology
- Immunology
- Critical Care Medicine
Background:
- Signal transducer and activator of transcription 3 (STAT3) is a crucial transcription factor involved in cellular responses to cytokines and growth factors.
- STAT3 regulates genes critical for both pro- and anti-inflammatory processes, impacting overall immune homeostasis.
- Sepsis, a life-threatening condition characterized by dysregulated host response to infection, involves complex inflammatory pathways where STAT3 acts as a central mediator.
Purpose of the Study:
- To review and evaluate existing literature on the role of STAT3 in experimental and clinical sepsis.
- To assess the therapeutic potential of targeting STAT3 for sepsis treatment.
- To explore STAT3's utility as a potential biomarker for sepsis.
Main Methods:
- Comprehensive literature search of studies investigating STAT3 in sepsis.
- Analysis of experimental models and clinical data related to STAT3 modulation in sepsis.
- Synthesis of findings regarding STAT3's involvement in sepsis pathophysiology and treatment.
Main Results:
- Accumulating evidence highlights STAT3 as a key player in the complex network of inflammatory pathways during sepsis.
- Studies indicate that modulating STAT3 activity can influence sepsis outcomes in experimental settings.
- The literature suggests a potential role for STAT3 in both the development and progression of sepsis.
Conclusions:
- Targeting STAT3 presents a promising therapeutic avenue for managing sepsis.
- STAT3 holds potential as a valuable biomarker for sepsis diagnosis or prognosis.
- Further research is warranted to fully elucidate STAT3's role and optimize its therapeutic targeting in sepsis.
Related Concept Videos
The JAK-STAT Signaling Pathway
PI3K/mTOR/AKT Signaling Pathway
Gene Regulation in Microbial Communities: Quorum Sensing
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Amplifying Signals via Enzymatic Cascade
Intracellular Signaling Affects Focal Adhesions
Some...

